Synchron
Synchron, a neurotechnology company, is hiring a researcher to work directly with participants using its brain-computer interface (BCI) product in Melbourne with regular travel within Australia. The role sits at the intersection of human neuroscience, applied machine learning, and real-world BCI deployment, partnering closely with ML, research engineering, clinical, and product teams to improve decoding performance and user experience.
Headquarters
Brooklyn, New York, United States
Company Size
51-200 employees
Founded
2016
Synchron is a neurotechnology company building an endovascular brain-computer interface platform to restore autonomy for people with paralysis by providing unprecedented access to brain data. Its flagship implant — a minimally invasive, stent-mounted electrode array (the Stentrode) delivered via the bloodstream — decodes neural signals to enable control of computers and digital devices without open-brain surgery. The company advances its technology through clinical research and trials and works with industry partners to integrate emerging BCI standards and consumer interfaces.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Synchron.
Synchron raises $200M to accelerate Stentrode BCI platform
Nov 10, 2025